Cisema to Present at PharmaSynergy-RX 2026 – China: Understanding the System Behind the Market
Cisema will be attending and presenting at PharmaSynergy-RX, a two-day forum bringing together more than 250 pharmaceutical professionals to explore collaboration models, regulatory pathways, and market access strategies across global pharmaceutical markets.
Meet Stefanie Fasshauer, Life Sciences Business Development Director at Cisema. Stefanie will be on site throughout the event and available to meet with companies planning China market entry and expansion opportunities across the pharmaceutical value chain.
About Pharma Synergy-RX 2026
PharmaSynergy-RX is a B2B industry forum focused on collaboration, compliance, and commercial strategy across global pharmaceutical markets, with a strong emphasis on regulatory alignment and market access.
The event is designed for companies seeking practical, execution-focused insights rather than high-level theory—particularly companies with portfolios spanning biosimilars, generics, value-added medicines, specialty products, and selected NCEs.
Dates: February 5–6, 2026
Location: etc.venues County Hall, London
Event Website: https://pharma-synergy-conference.com/
Presentation Details: Understanding the System Behind the Market
Within the global pharmaceutical landscape, China remains one of the most strategically important and complex markets. This raises a key question: what does it take to operate effectively within China’s pharmaceutical regulatory system?
Drawing on Chinese regulatory and market access experience, Stefanie Fasshauer will address this question in a focused session on February 6, covering:
- How China’s policy evolution defines realistic entry routes for foreign pharmaceutical products
- Key NMPA regulatory pathways for international companies
- Current market access dynamics and the requirements for effective collaboration in China
Date: February 6, 2026
Time: 09:30–09:55
Location: etc.venues County Hall, London
Continue the Conversation
For those looking to continue the discussion beyond the session, Stefanie Fasshauer will be available throughout PharmaSynergy-RX to meet one-to-one and discuss China regulatory or market access strategies for 2026 and beyond.
To learn more about how Cisema supports pharmaceutical companies across Asia Pacific, from regulatory strategy through market access and lifecycle support, explore Cisema’s Pharma Consulting services.